spacer TANAKA LAB. spacer
  田中研究室  
spacer イメージ spacer
spacer spacer
line_ico
line_ico
ico メンバー
line_ico
ico News & Information
spacer

Abstract (Nakata Y in AFSM 2005)


    Many studies have revealed that comprehensive lifestyle therapy, involving diet, exercise, and behavioral modification, can lead to improvements in coronary heart disease (CHD) risk factors. To sustain the effects of lifestyle therapy, long-term maintenance of the reduced weight and visceral fat would be required. However, many obese persons experience weight gains after relapsing toward their pre-intervention lifestyle. Few reports are currently available that indicate the extent to which gains of weight and visceral fat contribute to unfavorable effects on CHD risk factors. PURPOSE: To examine the effect of changes in weight and visceral fat on CHD risk factors after weight loss. METHODS: One hundred fourteen overweight and obese women (age 46.5 ± 8.0 years, BMI 27.6 ± 2.8 kg/m2) had participated in a 14-week weight-loss program and were retested 2 to 5 (3.6 ± 1.4) years later. The changes of weight, visceral fat area (VFA) estimated with computed tomography, and CHD risk factors [systolic and diastolic blood pressure (SBP, DBP), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDLC), and fasting plasma glucose (FPG)] were assessed before and after the weight-loss program and at follow-up. RESULTS: Body weight before and after the program averaged 67.7 ± 7.5 kg and 59.1 ± 7.0 kg, respectively, and the mean increased to 63.2 ± 8.0 kg at follow-up. With the moderate rebound of weight (+4.1 ± 3.5 kg), VFA increased slightly but significantly (+9.4 ± 25.9 cm2, P < 0.05). The weight change was significantly correlated with changes in SBP, DBP, and VFA (P < 0.05), and the VFA change was significantly correlated with change in DBP. Although TC, TG, LDLC, and FPG also increased (P < 0.05), they were not significantly associated with changes in weight and VFA. CONCLUSION: A moderate weight rebound was accompanied by relapses of CHD risk factor profiles. The extent of the relapses could not always be accounted for by the changes in weight and VFA.




Home

spacer
spacer

Copyright (C) 2004 Tanaka laboratory All Rights Reserved.

spacer

English here トップページへ